General Information of Drug (ID: DMFSXOM)

Drug Name
Gamma-acetylenic GABA
Synonyms
gamma-Acetylenic gaba; 4-Aminohex-5-ynoic acid; gamma-Acetylinic GABA; 4-Amino-5-hexynoic acid; 57659-38-8; RMI 71645; 5-Hexynoic acid, 4-amino-; RMI-71645; 4-aminohexynoate; gamma-acetylenic-GABA; Acetylenic GABA-7; AC1L1FYW; 4-ami-nohex-5-ynoic acid; AC1Q5VT0; 4-Amino-hex-5-ynoic acid; Lopac0_000138; SCHEMBL690785; CHEMBL330129; 4-Amino-5-hexynoic acid, solid; CTK5A7233; BDBM81477; HMS3260K18; Tox21_500138; PDSP2_000141; PDSP1_000142; AKOS006272245; LP00138; CCG-204233; NCGC00015019-02; NCGC00093628-02; NCGC00260823-01
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 1 Molecular Weight (mw) 127.14
Logarithm of the Partition Coefficient (xlogp) -3
Rotatable Bond Count (rotbonds) 3
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C6H9NO2
IUPAC Name
4-aminohex-5-ynoic acid
Canonical SMILES
C#CC(CCC(=O)O)N
InChI
InChI=1S/C6H9NO2/c1-2-5(7)3-4-6(8)9/h1,5H,3-4,7H2,(H,8,9)
InChIKey
BJNIHWSOVCDBHS-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
3452
CAS Number
57659-38-8
TTD ID
D09IHN

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
GABA transaminase (ABAT) TTT2LD9 GABT_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Treatment of Huntington disease with gamma-acetylenic GABA an irreversible inhibitor of GABA-transaminase: increased CSF GABA and homocarnosine without clinical amelioration. Neurology. 1981 Feb;31(2):207-11.